Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Introduction
Percutaneous coronary intervention (PCI) is a procedure used to treat the narrowing of coronary arteries. In this procedure, a catheter is used to place a small structure, i.e., a stent to open blood vessels in the heart that have been narrowed owing to plaque build-up. Factors such as the growing prevalence of cardiac diseases, the rising preference for minimally invasive procedures, and growing geriatric population are anticipated to propel the growth of the market over the forecast period.
Factors such as the rising prevalence of heart diseases and increasing preference for minimally invasive procedures are expected to fuel the demand for percutaneous coronary intervention. The increasing geriatric population is also propelling the growth of the market. However, the risk of infection and stringent government regulations are the major challenges for the market.
The global market for percutaneous coronary intervention has been segmented on the basis of product type, end user, and region. On the basis of product type, the market has been divided into coronary stents, PTCA catheters, and coronary guidewire and accessories. Coronary stents are further sub-segmented into drug-eluting stents, bare metal stents, and bioresorbable vascular scaffolds. PTCA catheters are further sub-segmented into balloon catheter and guiding catheter. By accessories, the product type segment is further categorized into inflation devices, torquer, RHV (Y-connector), control syringe, manifold, extension line, and others.
Based on end user, the market has been divided into hospitals and specialty clinics, ambulatory surgical centers, research and academic institutes, and others.
The global percutaneous coronary intervention market accounted for USD 8,679.1 million in 2015 and is expected to register a CAGR of 7.10 % during the forecast period.
Key Players
Some of the key players for the global percutaneous coronary intervention market are Abbott, ASAHI INTECC Company Limited, B. Braun Melsungen AG, Biosensors International Group, Ltd., BIOTRONIK, Boston Scientific Corporation, C. R. Bard, Inc, Comed B.V., Cook, Cordis, Medtronic Plc, Meril Lifesciences Pvt. Ltd, Merit Medical System, Terumo Corporation, and others.
Study Objectives
• To provide a detailed analysis of the market structure along with the forecast of various segments and sub-segments of the global percutaneous coronary intervention market
• To provide insights into factors influencing and affecting market growth
• To provide historical, current, and forecast revenue of market segments based on product type and end user
• To provide historical, current, and forecast revenue of market segments and sub-segments with respect to regional markets and key countries
• To provide strategic profiling of key players in the market, comprehensively analyzing their market shares, core competencies, and drawing a competitive landscape for the market
• To provide economic factors, technology trends, and market trends that influence the global percutaneous coronary intervention market
Target Audience
• Global percutaneous coronary intervention solution providers, manufacturers, and suppliers
• Research and development (R&D) companies
• Market research and consulting service providers
• Academic institutes and universities
Key Findings
• The global percutaneous coronary intervention market is expected to reach a value of USD 15,205.4 million by 2023 at a CAGR of 7.10%.
• On the basis of product type, the coronary stents segment is projected to be largest, registering a CAGR of 7.81% during the forecast period.
• By end user, the hospitals and clinics segment is expected to be the largest at USD 6,680.0 million by 2023.
• On the basis of region, the market has been segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas market is expected to be the largest at an estimated value of USD 6,068.7 million by 2023.
• Asia-Pacific is projected to be the fastest-growing market at a CAGR of 8.14% from 2018 to 2023.
Regional Analysis
• Americas
o North America
US
Canada
o South America
• Europe
o Western Europe
Germany
France
UK
Italy
Spain
Rest of Europe
o Eastern Europe
• Asia-Pacific
o Japan
o China
o India
o South Korea
o Australia
o Rest of Asia-Pacific
• Middle East & Africa
o Middle East
o Africa
Percutaneous coronary intervention (PCI) is a procedure used to treat the narrowing of coronary arteries. In this procedure, a catheter is used to place a small structure, i.e., a stent to open blood vessels in the heart that have been narrowed owing to plaque build-up. Factors such as the growing prevalence of cardiac diseases, the rising preference for minimally invasive procedures, and growing geriatric population are anticipated to propel the growth of the market over the forecast period.
Factors such as the rising prevalence of heart diseases and increasing preference for minimally invasive procedures are expected to fuel the demand for percutaneous coronary intervention. The increasing geriatric population is also propelling the growth of the market. However, the risk of infection and stringent government regulations are the major challenges for the market.
The global market for percutaneous coronary intervention has been segmented on the basis of product type, end user, and region. On the basis of product type, the market has been divided into coronary stents, PTCA catheters, and coronary guidewire and accessories. Coronary stents are further sub-segmented into drug-eluting stents, bare metal stents, and bioresorbable vascular scaffolds. PTCA catheters are further sub-segmented into balloon catheter and guiding catheter. By accessories, the product type segment is further categorized into inflation devices, torquer, RHV (Y-connector), control syringe, manifold, extension line, and others.
Based on end user, the market has been divided into hospitals and specialty clinics, ambulatory surgical centers, research and academic institutes, and others.
The global percutaneous coronary intervention market accounted for USD 8,679.1 million in 2015 and is expected to register a CAGR of 7.10 % during the forecast period.
Key Players
Some of the key players for the global percutaneous coronary intervention market are Abbott, ASAHI INTECC Company Limited, B. Braun Melsungen AG, Biosensors International Group, Ltd., BIOTRONIK, Boston Scientific Corporation, C. R. Bard, Inc, Comed B.V., Cook, Cordis, Medtronic Plc, Meril Lifesciences Pvt. Ltd, Merit Medical System, Terumo Corporation, and others.
Study Objectives
• To provide a detailed analysis of the market structure along with the forecast of various segments and sub-segments of the global percutaneous coronary intervention market
• To provide insights into factors influencing and affecting market growth
• To provide historical, current, and forecast revenue of market segments based on product type and end user
• To provide historical, current, and forecast revenue of market segments and sub-segments with respect to regional markets and key countries
• To provide strategic profiling of key players in the market, comprehensively analyzing their market shares, core competencies, and drawing a competitive landscape for the market
• To provide economic factors, technology trends, and market trends that influence the global percutaneous coronary intervention market
Target Audience
• Global percutaneous coronary intervention solution providers, manufacturers, and suppliers
• Research and development (R&D) companies
• Market research and consulting service providers
• Academic institutes and universities
Key Findings
• The global percutaneous coronary intervention market is expected to reach a value of USD 15,205.4 million by 2023 at a CAGR of 7.10%.
• On the basis of product type, the coronary stents segment is projected to be largest, registering a CAGR of 7.81% during the forecast period.
• By end user, the hospitals and clinics segment is expected to be the largest at USD 6,680.0 million by 2023.
• On the basis of region, the market has been segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas market is expected to be the largest at an estimated value of USD 6,068.7 million by 2023.
• Asia-Pacific is projected to be the fastest-growing market at a CAGR of 8.14% from 2018 to 2023.
Regional Analysis
• Americas
o North America
US
Canada
o South America
• Europe
o Western Europe
Germany
France
UK
Italy
Spain
Rest of Europe
o Eastern Europe
• Asia-Pacific
o Japan
o China
o India
o South Korea
o Australia
o Rest of Asia-Pacific
• Middle East & Africa
o Middle East
o Africa
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
